Macrophage migration-inhibitory factor is elevated in pregnant women with gestational diabetes mellitus. 2012

Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
Department of Obstetrics and Gynecology, Akhisar State Hospital, Akhisar, Manisa, Turkey. ozgur_md@yahoo.com

OBJECTIVE In reports, abnormal macrophage migration-inhibitory factor (MIF) production has been associated with several diseases. Furthermore, despite scarce data, increasing evidence suggest that MIF plays a central role in glucose homeostasis and in the development of type 1 and type 2 diabetes. However, serum MIF levels in gestational diabetes mellitus (GDM) have not yet been investigated. To address this question, we performed a prospective study between a group of pregnant women with GDM and healthy pregnant controls. METHODS GDM group consisted of 43 pregnant women, whereas the control group consisted of 40 healthy pregnant women. In the morning after an overnight fast, venous blood was sampled for the measurement of serum concentrations of insulin and MIF. Serum was separated by centrifugation and immediately stored at -80°C until the assay. RESULTS There was no significant difference between the groups for maternal characteristics. Women with GDM had significantly higher levels of serum insulin (14.37 ± 9.92 µU/ml vs. 8.78 ± 4.35 µU/ml; p = 0.001) and serum MIF concentrations (11.31 ± 4.92 ng/ml vs. 5.31 ± 4.07 ng/ml; p < 0.001) when compared with healthy pregnant control group. CONCLUSIONS Our data demonstrated that serum levels of MIF are significantly elevated in patients with GDM. Our findings indicate that MIF might have a role in GDM; however, there is a need for further investigation.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008263 Macrophage Migration-Inhibitory Factors Proteins released by sensitized LYMPHOCYTES and possibly other cells that inhibit the migration of MACROPHAGES away from the release site. The structure and chemical properties may vary with the species and type of releasing cell. Macrophage Migration Inhibitory Factor,Migration Inhibition Factors, Macrophage,Macrophage Migration Inhibition Factors,Migration Inhibition Factor, Macrophage,Macrophage Migration Inhibitory Factors,Migration-Inhibitory Factors, Macrophage
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015992 Body Mass Index An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI Quetelet Index,Quetelet's Index,Index, Body Mass,Index, Quetelet,Quetelets Index

Related Publications

Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
January 2016, Gynecologic and obstetric investigation,
Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
July 2011, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
October 2012, Archives of physiology and biochemistry,
Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
November 2017, Zhonghua yi xue za zhi,
Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
August 2011, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
June 2008, Journal of cellular physiology,
Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
February 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
February 2000, Diabetes care,
Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
January 2020, Current diabetes reviews,
Özgür Yilmaz, and Mert Küçük, and Levent Kebapçilar, and Tamer Altindag, and Arif Yüksel, and Hüseyin Oguz Yuvanç, and Tuba Dal, and Yusuf Savran
December 2014, Journal of lipid research,
Copied contents to your clipboard!